WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007098283) USE OF ANTAGONISTS OF MAIF RECEPTOR COMPLEX MOLECULES AND NEUROTROPHIC FACTORS FOR TREATMENT OF NEUROLOGICAL DISEASES AND DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/098283    International Application No.:    PCT/US2007/005078
Publication Date: 30.08.2007 International Filing Date: 27.02.2007
IPC:
A61K 38/18 (2006.01)
Applicants: BIOGEN IDEC MA INC. [US/US]; 14 Cambridge Center, Cambridge, MA 02142 (US) (For All Designated States Except US).
LEE, Daniel, H.S. [US/US]; (US) (For US Only).
ROSSOMANDO, Anthony [US/US]; (US) (For US Only).
WEINREB, Paul, H. [US/US]; (US) (For US Only)
Inventors: LEE, Daniel, H.S.; (US).
ROSSOMANDO, Anthony; (US).
WEINREB, Paul, H.; (US)
Agent: HAANES, Elizabeth, J.; Sterne, Kessler, Goldstein & Fox P.L.L.C., 1100 New York Avenue, N.W., Washington, DC 20005-3934 (US)
Priority Data:
60/776,657 27.02.2006 US
60/831,459 18.07.2006 US
Title (EN) USE OF ANTAGONISTS OF MAIF RECEPTOR COMPLEX MOLECULES AND NEUROTROPHIC FACTORS FOR TREATMENT OF NEUROLOGICAL DISEASES AND DISORDERS
(FR) UTILISATION D'ANTAGONISTES DE MOLÉCULES COMPLEXES DU RÉCEPTEUR MAIF (MACROPHAGE MIGRATION-INHIBITORY FACTORS) ET DE FACTEURS NEUROTROPHIQUES POUR TRAITER DES MALADIES ET DES TROUBLES NEUROLOGIQUES
Abstract: front page image
(EN)The invention provides methods of treating diseases, disorders, injuries, or conditions involving modulating neurite outgrowth and/or survival, and axonal regeneration including CNS disorders, stroke, or spinal injury, by administration of a MAIF receptor complex molecule antagonist and a neurotrophic factor.
(FR)L'invention concerne des méthodes pour traiter des maladies, des troubles, des lésions ou des affections impliquant la modulation de la croissances et/ou survie de neurites et de la régénération axonale, y compris des troubles du SNC, un accident cérébrovasculaire ou une lésion de la colonne vertébrale, par l'administration d'un antagoniste de molécule complexe du récepteur MAIF et d'un facteur neurotrophique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)